maprotiline and nomifensine

maprotiline has been researched along with nomifensine in 37 studies

Research

Studies (37)

TimeframeStudies, this research(%)All Research%
pre-199025 (67.57)18.7374
1990's3 (8.11)18.2507
2000's3 (8.11)29.6817
2010's6 (16.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Anlezark, G; Meldrum, BS; Trimble, MR1
Campbell, IC; Ellison, DW1
Maletta, GJ1
Ostrow, D1
Brown, TM; Evans, DL; Golden, RN; Miller, H1
Hayes, PE; Kristoff, CA1
Gelbtuch, MH; Harris, JP; Phillipson, OT1
Calvert, JE; Gelbtuch, MH; Harris, JP; Phillipson, OT1
Blansjaar, BA; Dijken, WA; Haffmans, J; Kamp, JS; Kramer, HJ; Nolen, WA; van de Putte, JJ1
Seppälä, T; Strömberg, C; Suokas, A1
Faltus, F; Filip, V; Karen, P; Kolomazník, M; Korínková, V; Libiger, J; Molcan, J; Zapletálek, M; Zizka, V1
O'Connolly, M; Siegfried, K1
Adams, C; Gastpar, M; Kielholz, P; Terzani, S1
Ballinger, BR; Feely, J1
Golden, RN; Potter, WZ; Rudorfer, MV1
Montgomery, SA1
Desager, JP; Harvengt, C1
Balon, R; Dostal, T; Kabes, J; Papezová, H1
Levin, A1
Devoize, JL; Eschalier, A; Pechadre, JC; Rigal, F1
King, DJ1
Hollister, LE1
Laakmann, G1
Bergener, M; Hesse, C1
Balon, R; Dostal, T; Kabes, J1
Bech, P1
Götz, E; Meyer, DK; Mondeh, JD; Olenik, C; Uhl, A1
Egashira, T; Takayama, F; Yamanaka, Y1
Obata, T; Yamanaka, Y1

Reviews

8 review(s) available for maprotiline and nomifensine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
The new antidepressants.
    North Carolina medical journal, 1988, Volume: 49, Issue:10

    Topics: Alprazolam; Amoxapine; Antidepressive Agents; Fluoxetine; Maprotiline; Nomifensine; Seizures; Trazodone

1988
Adverse reactions to five new antidepressants.
    Clinical pharmacy, 1986, Volume: 5, Issue:6

    Topics: Acute Kidney Injury; Amoxapine; Animals; Antidepressive Agents; Bupropion; Cardiovascular Diseases; Dopamine Antagonists; Humans; Male; Maprotiline; Nomifensine; Priapism; Propiophenones; Seizures; Trazodone

1986
Second-generation antidepressants.
    The Psychiatric clinics of North America, 1984, Volume: 7, Issue:3

    Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Dopamine; Double-Blind Method; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Seizures; Serotonin; Trazodone; Zimeldine

1984
Maprotiline, nomifensine, mianserin, zimelidine: a review of antidepressant efficacy in in-patients.
    Neuropharmacology, 1980, Volume: 19, Issue:12

    Topics: Antidepressive Agents; Brompheniramine; Clinical Trials as Topic; Depression; Humans; Maprotiline; Mianserin; Nomifensine; Psychiatric Status Rating Scales; Zimeldine

1980
New developments in antidepressant medication--a review.
    Irish medical journal, 1980, Volume: 73, Issue:10

    Topics: Antidepressive Agents; Flupenthixol; Humans; Maprotiline; Mianserin; Nomifensine; Structure-Activity Relationship; Viloxazine

1980
'Second generation' antidepressant drugs.
    Psychosomatics, 1981, Volume: 22, Issue:10

    Topics: Amoxapine; Antidepressive Agents; Antidepressive Agents, Tricyclic; Clomipramine; Humans; Maprotiline; Mianserin; Nomifensine; Trazodone; Viloxazine

1981
Acute therapy of depression.
    The Journal of clinical psychiatry, 1993, Volume: 54 Suppl

    Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzamides; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Humans; Maprotiline; Meta-Analysis as Topic; Moclobemide; Monoamine Oxidase Inhibitors; Nomifensine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index

1993

Trials

9 trial(s) available for maprotiline and nomifensine

ArticleYear
The new generation antidepressants: promising innovations or disappointments?
    The Journal of clinical psychiatry, 1985, Volume: 46, Issue:10 Pt 2

    Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Depressive Disorder; Dopamine; Drug Evaluation; Fluoxetine; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Receptors, Neurotransmitter; Serotonin; Trazodone; Zimeldine

1985
Effects of haloperidol and nomifensine on the visual aftereffects of tilt and movement.
    Psychopharmacology, 1986, Volume: 89, Issue:2

    Topics: Adult; Afterimage; Arousal; Eye Movements; Female; Haloperidol; Humans; Male; Maprotiline; Motion; Movement; Nomifensine; Posture; Reaction Time; Sleep Stages; Visual Acuity

1986
Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine.
    Acta psychiatrica Scandinavica, 1988, Volume: 78, Issue:6

    Topics: 5-Hydroxytryptophan; Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Female; Fluvoxamine; Humans; Male; Maprotiline; Middle Aged; Nomifensine; Oximes; Psychological Tests; Tranylcypromine

1988
Interaction of alcohol with maprotiline or nomifensine: echocardiographic and psychometric effects.
    European journal of clinical pharmacology, 1988, Volume: 35, Issue:6

    Topics: Adolescent; Adult; Anthracenes; Double-Blind Method; Drug Interactions; Echocardiography; Ethanol; Female; Humans; Male; Maprotiline; Nomifensine; Psychomotor Performance

1988
[Comparison of nomifensine, maprotiline and imipramine in a double-blind study of patients with endogenous depression].
    Ceskoslovenska psychiatrie, 1986, Volume: 82, Issue:2

    Topics: Adult; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Maprotiline; Middle Aged; Nomifensine

1986
Cognitive and psychomotor effects of different antidepressants in the treatment of old age depression.
    International clinical psychopharmacology, 1986, Volume: 1, Issue:3

    Topics: Aged; Anthracenes; Antidepressive Agents; Clinical Trials as Topic; Cognition; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Mianserin; Nomifensine; Psychomotor Performance; Random Allocation

1986
Second-generation antidepressants.
    The Psychiatric clinics of North America, 1984, Volume: 7, Issue:3

    Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Dopamine; Double-Blind Method; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Seizures; Serotonin; Trazodone; Zimeldine

1984
Maprotiline, nomifensine, mianserin, zimelidine: a review of antidepressant efficacy in in-patients.
    Neuropharmacology, 1980, Volume: 19, Issue:12

    Topics: Antidepressive Agents; Brompheniramine; Clinical Trials as Topic; Depression; Humans; Maprotiline; Mianserin; Nomifensine; Psychiatric Status Rating Scales; Zimeldine

1980
Nomifensine and maprotiline in endogenous depression: comparative efficacy and side effects.
    International pharmacopsychiatry, 1982, Volume: 17 Suppl 1

    Topics: Adolescent; Adult; Aged; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Isoquinolines; Male; Maprotiline; Middle Aged; Nomifensine

1982

Other Studies

22 other study(ies) available for maprotiline and nomifensine

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
Effect of nomifensine on brain amines and epilepsy in photosensitive baboons.
    British journal of clinical pharmacology, 1977, Volume: 4Suppl 2

    Topics: Amines; Animals; Brain Chemistry; Clomipramine; Dose-Response Relationship, Drug; Imipramine; Isoquinolines; Maprotiline; Nomifensine; Papio; Photic Stimulation; Seizures

1977
Studies on the role of alpha 2-adrenoceptors in the control of synaptosomal [3H]5-hydroxytryptamine release: effects of antidepressant drugs.
    Journal of neurochemistry, 1986, Volume: 46, Issue:1

    Topics: Animals; Antidepressive Agents; Benzylamines; Cerebral Cortex; Citalopram; Clonidine; Clorgyline; Desipramine; Hydroxyindoleacetic Acid; Male; Maprotiline; Nomifensine; Potassium; Propylamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Serotonin; Synaptosomes; Yohimbine

1986
Medications to modify at-home behavior of Alzheimer's patients.
    Geriatrics, 1985, Volume: 40, Issue:12

    Topics: Aged; Alzheimer Disease; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Behavior; Benzodiazepines; Electroconvulsive Therapy; Humans; Lithium; Maprotiline; Middle Aged; Monoamine Oxidase Inhibitors; Nomifensine; Psychotropic Drugs; Trazodone

1985
Modification of visual orientation illusions by drugs which influence dopamine and GABA neurones: differential effects on simultaneous and successive illusions.
    Psychopharmacology, 1986, Volume: 90, Issue:3

    Topics: Adolescent; Adult; Dopamine; Female; gamma-Aminobutyric Acid; Haloperidol; Humans; Illusions; Lorazepam; Male; Maprotiline; Neurons; Nomifensine; Optical Illusions; Orientation

1986
[Management of treatment-resistant depression without ECT (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1981, May-22, Volume: 106, Issue:21

    Topics: Antipsychotic Agents; Clomipramine; Depressive Disorder; Female; Humans; Male; Maprotiline; Nomifensine; Physical Therapy Modalities; Psychotherapy

1981
Antidepressants.
    British medical journal (Clinical research ed.), 1983, Jun-11, Volume: 286, Issue:6381

    Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Brompheniramine; Humans; Maprotiline; Mianserin; Nomifensine; Trazodone; Viloxazine; Zimeldine

1983
Relative acute cardiovascular toxicity induced by maprotiline, mianserin and nomifensine in conscious rabbits.
    Journal of toxicology. Clinical toxicology, 1983, Volume: 20, Issue:3

    Topics: Animals; Anthracenes; Blood Gas Analysis; Cardiac Output; Dibenzazepines; Epinephrine; Hemodynamics; Injections, Intraperitoneal; Isoquinolines; Male; Maprotiline; Mianserin; Nomifensine; Norepinephrine; Rabbits; Renal Circulation

1983
[A profile of the clinical effectiveness of second generation antidepressive agents].
    Ceskoslovenska psychiatrie, 1984, Volume: 80, Issue:1

    Topics: Adult; Anthracenes; Depressive Disorder; Female; Humans; Isoquinolines; Male; Maprotiline; Middle Aged; Morpholines; Nomifensine; Viloxazine

1984
Activities of five antidepressants in a behavioral pain test in rats.
    Life sciences, 1983, Jun-27, Volume: 32, Issue:26

    Topics: Analgesia; Animals; Antidepressive Agents; Clomipramine; Desipramine; Electroshock; Male; Maprotiline; Nociceptors; Nomifensine; Rats; Rats, Inbred Strains; Viloxazine

1983
[Effect of antidepressants on the secretion of pituitary hormones in healthy subjects, neurotic depressive patients and endogenous depressive patients (author's transl)].
    Der Nervenarzt, 1980, Volume: 51, Issue:12

    Topics: Adult; Anthracenes; Clomipramine; Depressive Disorder; Desipramine; Female; Growth Hormone; Humans; Isoquinolines; Luteinizing Hormone; Male; Maprotiline; Middle Aged; Nomifensine; Pituitary Hormones, Anterior; Prolactin; Thyrotropin

1980
A biological concept for diagnosis, treatment and therapy control of endogenous psychoses.
    Neurosurgical review, 1980, Volume: 3, Issue:4

    Topics: Age Factors; Aged; Antidepressive Agents; Benzodiazepines; Depression; Humans; Maprotiline; Nomifensine; Psychotic Disorders

1980
Do have antidepressants of the second generation anxiolytic properties?
    Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression, 1981, Volume: 22, Issue:E

    Topics: Adult; Anthracenes; Anxiety; Depressive Disorder; Humans; Isoquinolines; Maprotiline; Middle Aged; Morpholines; Nomifensine; Psychiatric Status Rating Scales; Viloxazine

1981
Cerebral cortex injury: effect of blockers of re-uptake of catecholamines.
    European journal of pharmacology, 1993, Aug-10, Volume: 240, Issue:1

    Topics: Animals; Catecholamines; Cerebral Cortex; Cholecystokinin; Male; Maprotiline; Neurotransmitter Uptake Inhibitors; Nomifensine; Protein Precursors; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; RNA, Messenger; Sympathetic Nervous System

1993
The inhibition of monoamine oxidase activity by various antidepressants: differences found in various mammalian species.
    Japanese journal of pharmacology, 1999, Volume: 81, Issue:1

    Topics: Animals; Antidepressive Agents; Binding, Competitive; Brain; Dogs; Imipramine; Isoenzymes; Kinetics; Macaca; Male; Maprotiline; Mice; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nomifensine; Rats; Rats, Wistar; Species Specificity; Zimeldine

1999
Inhibition of monkey brain semicarbazide-sensitive amine oxidase by various antidepressants.
    Neuroscience letters, 2000, Jun-02, Volume: 286, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Amine Oxidase (Copper-Containing); Animals; Antidepressive Agents; Brain; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Imipramine; Macaca; Male; Maprotiline; Neurons; Nomifensine; Selective Serotonin Reuptake Inhibitors; Time Factors; Zimeldine

2000